RecruitingNCT07769151

BIO-FUNCTION for Prediction Non Relapse Mortality in Transplant and Cell Therapy

BIO-FUNCTION for NRM Prediction in SCTCT: Assessing Biological and Functional Reserve to Predict Non-Relapse Mortality in Stem Cell Transplant and Cell Therapy

Sponsor

Henry Ford Health System

Enrollment

124 participants

Start Date

Sep 1, 2026

Study Type

OBSERVATIONAL

Conditions

Mortality Prediction

Summary

The purpose of this research is test if combination of physical tests and blood tests drawn before SCTCT can predict NRM.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying blood sample to check CXCL9 pre stem cell transplant and cell therapy for people with mortality prediction. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTblood sample to check CXCL9 pre stem cell transplant and cell therapy

Pre SCTCT as per SOC physical function assessment will be performed in a form of IADl, hand grip, and or walk test like TUG. Specimen Collection Studies: LDH , albumin, ferritin, CRP, platelet and creatinine will be collected as per standard of care pre SCTCT. The non-SOC procedure will be drawing CXL9